DVAX
Dynavax Technologies Corp
Price:  
10.74 
USD
Volume:  
1,334,052.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX Relative Valuation

-96.5%
Upside

As of 2025-07-15, the Relative Valuation of Dynavax Technologies Corp (DVAX) is 0.38 USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.74 USD, the upside of Dynavax Technologies Corp based on Relative Valuation is -96.5%.

The range of the Relative Valuation is (8.17) - 11.01 USD.

Range Selected
Trailing P/E multiples 16.3x - 24.3x 20.3x
Forward P/E multiples 31.8x - 32.4x 32.1x
Fair Price (8.17) - 11.01 0.38
Upside -176.1% - 2.5% -96.5%
10.74 USD
Stock Price
0.38 USD
Fair Price

DVAX Relative Valuation - Historical P/E Data

Date P/E
2025-07-11 -21.55
2025-07-10 -21.79
2025-07-09 -21.61
2025-07-08 -21.17
2025-07-07 -20.59
2025-07-03 -20.53
2025-07-02 -20.31
2025-07-01 -20.11
2025-06-30 -19.83
2025-06-27 -19.81
2025-06-26 -19.87
2025-06-25 -19.71
2025-06-24 -19.81
2025-06-23 -19.53
2025-06-20 -19.97
2025-06-18 -20.59
2025-06-17 -19.97
2025-06-16 -20.33
2025-06-13 -20.53
2025-06-12 -20.79
2025-06-11 -20.35
2025-06-10 -20.85
2025-06-09 -20.55
2025-06-06 -20.47
2025-06-05 -19.89
2025-06-04 -19.77
2025-06-03 -20.01
2025-06-02 -19.67
2025-05-30 -19.57
2025-05-29 -19.51
2025-05-28 -18.99
2025-05-27 -19.55
2025-05-23 -19.59
2025-05-22 -19.63
2025-05-21 -19.79
2025-05-20 -20.83
2025-05-19 -19.65
2025-05-16 -19.33
2025-05-15 -19.01
2025-05-14 -18.79
2025-05-13 -19.23
2025-05-12 -19.69
2025-05-09 -18.81
2025-05-08 -19.37
2025-05-07 -19.43
2025-05-06 -21.83
2025-05-05 -22.51
2025-05-02 -22.65
2025-05-01 -22.95
2025-04-30 -23.49